AbbVie launches Produodopa for treatment of parkinson's disease in EU
Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
Subscribe To Our Newsletter & Stay Updated